CTLA-2 Alpha Is a Potent Inhibitor of Angiogenesis in Murine Ocular Tissue.

Maruyama, Kazuichi; Yoneda, Kazuhito; Sugita, Sunao; Yamamoto, Yoshimi; Koike, Masato; Peters, Christoph; Uchiyama, Yasuo; Nishida, Kohji

Maruyama, Kazuichi; Yoneda, Kazuhito; Sugita, Sunao; Yamamoto, Yoshimi; Koike, Masato; Peters, Christoph; Uchiyama, Yasuo; Nishida, Kohji.

Afiliación

Maruyama K; Department of Vision Informatics, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.
Yoneda K; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Osaka 565-0871, Japan.
Sugita S; Department of Ophthalmology, Kyoto Prefectural University Graduate School of Medicine, Kyoto 602-0841, Japan.
Yamamoto Y; RIKEN Center for Development Biology, Kobe 650-0047, Japan.
Koike M; Laboratory of Biochemistry and Radiation Biology, Department of Veterinary Science, Faculty of Agriculture, Yamaguchi University, Yamaguchi 753-8511, Japan.
Peters C; Department of Cell Biology and Neuroscience, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Uchiyama Y; Institute of Molecular Medicine and Cell Research, University of Freiburg, 79098 Freiburg, Germany.
Nishida K; Department of Cellular and Molecular Neuropathology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.

Antioxidants (Basel) ; 10(3)2021 Mar 15.

Article en En | MEDLINE | ID: mdl-33804126

Palabras clave

angiogenesis; choroidal neovascularization; corneal inflammation; cytotoxic T lymphocyte antigen-2 alpha

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Antioxidants (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google